MedPath
FDA Approval

Metaxalone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
RedPharm Drug, Inc.
DUNS: 828374897
Effective Date
January 20, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metaxalone(800 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RedPharm Drug, Inc.

RedPharm Drug, Inc.

828374897

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

NDC Product Code
67296-0993
Application Number
ANDA203399
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 20, 2022
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACT
CALCIUM CARBONATEInactive
Code: H0G9379FGKClass: IACT
Code: 1NMA9J598YClass: ACTIBQuantity: 800 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath